Global Recombinant Hirudin Supply, Demand and Key Producers, 2023-2029

Description

The global Recombinant Hirudin market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Hirudin is the most potent natural inhibitor of thrombin. Unlike antithrombin, hirudin binds to and inhibits only the activity of thrombin, with a specific activity on fibrinogen. Therefore, hirudin prevents or dissolves the formation of clots and thrombi (i.e., it has a thrombolytic activity), and has therapeutic value in blood coagulation disorders, in the treatment of skin hematomas and of superficial varicose veins, either as an injectable or a topical application cream. In some aspects, hirudin has advantages over more commonly used anticoagulants and thrombolytics, such as heparin, as it does not interfere with the biological activity of other serum proteins, and can also act on complexed thrombin.

It is difficult to extract large amounts of hirudin from natural sources, so a method for producing and purifying this protein using recombinant biotechnology has been developed. This has led to the development and marketing of a number of hirudin-based anticoagulant pharmaceutical products. Several other direct thrombin inhibitors are derived chemically from hirudin.

Recombinant Hirudin is derived from yeast and the polypeptide chain contains 65 amino acids and its Mw is 6979.5 Dalton which is identical to natural Hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. The Recombinant Hirudin is purified by proprietary chromatographic techniques.

This report studies the global Recombinant Hirudin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Hirudin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Hirudin that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Hirudin total production and demand, 2018-2029, (K Units)
Global Recombinant Hirudin total production value, 2018-2029, (USD Million)
Global Recombinant Hirudin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Hirudin consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Hirudin domestic production, consumption, key domestic manufacturers and share
Global Recombinant Hirudin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Hirudin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Hirudin production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Recombinant Hirudin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, The Medicines Company, Teva Pharmaceutical, Pfizer, Pentapharm, PrimeGene, Aniara Diagnostica, Bioassay Technology Laboratory and Novus Biologicals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Hirudin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Hirudin Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Recombinant Hirudin Market, Segmentation by Type
    12000ATU/mg
    16000ATU/mg

Global Recombinant Hirudin Market, Segmentation by Application
    Thrombosis Disease
    Tumor Disease

Companies Profiled:
    Abbott
    The Medicines Company
    Teva Pharmaceutical
    Pfizer
    Pentapharm
    PrimeGene
    Aniara Diagnostica
    Bioassay Technology Laboratory
    Novus Biologicals
    Merck KGaA

Key Questions Answered
1. How big is the global Recombinant Hirudin market?
2. What is the demand of the global Recombinant Hirudin market?
3. What is the year over year growth of the global Recombinant Hirudin market?
4. What is the production and production value of the global Recombinant Hirudin market?
5. Who are the key producers in the global Recombinant Hirudin market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Recombinant Hirudin Introduction
    1.2 World Recombinant Hirudin Supply & Forecast
        1.2.1 World Recombinant Hirudin Production Value (2018 & 2022 & 2029)
        1.2.2 World Recombinant Hirudin Production (2018-2029)
        1.2.3 World Recombinant Hirudin Pricing Trends (2018-2029)
    1.3 World Recombinant Hirudin Production by Region (Based on Production Site)
        1.3.1 World Recombinant Hirudin Production Value by Region (2018-2029)
        1.3.2 World Recombinant Hirudin Production by Region (2018-2029)
        1.3.3 World Recombinant Hirudin Average Price by Region (2018-2029)
        1.3.4 North America Recombinant Hirudin Production (2018-2029)
        1.3.5 Europe Recombinant Hirudin Production (2018-2029)
        1.3.6 China Recombinant Hirudin Production (2018-2029)
        1.3.7 Japan Recombinant Hirudin Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Recombinant Hirudin Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Recombinant Hirudin Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Recombinant Hirudin Demand (2018-2029)
    2.2 World Recombinant Hirudin Consumption by Region
        2.2.1 World Recombinant Hirudin Consumption by Region (2018-2023)
        2.2.2 World Recombinant Hirudin Consumption Forecast by Region (2024-2029)
    2.3 United States Recombinant Hirudin Consumption (2018-2029)
    2.4 China Recombinant Hirudin Consumption (2018-2029)
    2.5 Europe Recombinant Hirudin Consumption (2018-2029)
    2.6 Japan Recombinant Hirudin Consumption (2018-2029)
    2.7 South Korea Recombinant Hirudin Consumption (2018-2029)
    2.8 ASEAN Recombinant Hirudin Consumption (2018-2029)
    2.9 India Recombinant Hirudin Consumption (2018-2029)

3 World Recombinant Hirudin Manufacturers Competitive Analysis
    3.1 World Recombinant Hirudin Production Value by Manufacturer (2018-2023)
    3.2 World Recombinant Hirudin Production by Manufacturer (2018-2023)
    3.3 World Recombinant Hirudin Average Price by Manufacturer (2018-2023)
    3.4 Recombinant Hirudin Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Recombinant Hirudin Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Recombinant Hirudin in 2022
        3.5.3 Global Concentration Ratios (CR8) for Recombinant Hirudin in 2022
    3.6 Recombinant Hirudin Market: Overall Company Footprint Analysis
        3.6.1 Recombinant Hirudin Market: Region Footprint
        3.6.2 Recombinant Hirudin Market: Company Product Type Footprint
        3.6.3 Recombinant Hirudin Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Recombinant Hirudin Production Value Comparison
        4.1.1 United States VS China: Recombinant Hirudin Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Recombinant Hirudin Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Recombinant Hirudin Production Comparison
        4.2.1 United States VS China: Recombinant Hirudin Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Recombinant Hirudin Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Recombinant Hirudin Consumption Comparison
        4.3.1 United States VS China: Recombinant Hirudin Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Recombinant Hirudin Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Recombinant Hirudin Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Recombinant Hirudin Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Recombinant Hirudin Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Recombinant Hirudin Production (2018-2023)
    4.5 China Based Recombinant Hirudin Manufacturers and Market Share
        4.5.1 China Based Recombinant Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Recombinant Hirudin Production Value (2018-2023)
        4.5.3 China Based Manufacturers Recombinant Hirudin Production (2018-2023)
    4.6 Rest of World Based Recombinant Hirudin Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Recombinant Hirudin Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Recombinant Hirudin Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Recombinant Hirudin Production (2018-2023)

5 Market Analysis by Type
    5.1 World Recombinant Hirudin Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 12000ATU/mg
        5.2.2 16000ATU/mg
    5.3 Market Segment by Type
        5.3.1 World Recombinant Hirudin Production by Type (2018-2029)
        5.3.2 World Recombinant Hirudin Production Value by Type (2018-2029)
        5.3.3 World Recombinant Hirudin Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Recombinant Hirudin Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Thrombosis Disease
        6.2.2 Tumor Disease
    6.3 Market Segment by Application
        6.3.1 World Recombinant Hirudin Production by Application (2018-2029)
        6.3.2 World Recombinant Hirudin Production Value by Application (2018-2029)
        6.3.3 World Recombinant Hirudin Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Details
        7.1.2 Abbott Major Business
        7.1.3 Abbott Recombinant Hirudin Product and Services
        7.1.4 Abbott Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Abbott Recent Developments/Updates
        7.1.6 Abbott Competitive Strengths & Weaknesses
    7.2 The Medicines Company
        7.2.1 The Medicines Company Details
        7.2.2 The Medicines Company Major Business
        7.2.3 The Medicines Company Recombinant Hirudin Product and Services
        7.2.4 The Medicines Company Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 The Medicines Company Recent Developments/Updates
        7.2.6 The Medicines Company Competitive Strengths & Weaknesses
    7.3 Teva Pharmaceutical
        7.3.1 Teva Pharmaceutical Details
        7.3.2 Teva Pharmaceutical Major Business
        7.3.3 Teva Pharmaceutical Recombinant Hirudin Product and Services
        7.3.4 Teva Pharmaceutical Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Teva Pharmaceutical Recent Developments/Updates
        7.3.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer Recombinant Hirudin Product and Services
        7.4.4 Pfizer Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 Pentapharm
        7.5.1 Pentapharm Details
        7.5.2 Pentapharm Major Business
        7.5.3 Pentapharm Recombinant Hirudin Product and Services
        7.5.4 Pentapharm Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Pentapharm Recent Developments/Updates
        7.5.6 Pentapharm Competitive Strengths & Weaknesses
    7.6 PrimeGene
        7.6.1 PrimeGene Details
        7.6.2 PrimeGene Major Business
        7.6.3 PrimeGene Recombinant Hirudin Product and Services
        7.6.4 PrimeGene Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 PrimeGene Recent Developments/Updates
        7.6.6 PrimeGene Competitive Strengths & Weaknesses
    7.7 Aniara Diagnostica
        7.7.1 Aniara Diagnostica Details
        7.7.2 Aniara Diagnostica Major Business
        7.7.3 Aniara Diagnostica Recombinant Hirudin Product and Services
        7.7.4 Aniara Diagnostica Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Aniara Diagnostica Recent Developments/Updates
        7.7.6 Aniara Diagnostica Competitive Strengths & Weaknesses
    7.8 Bioassay Technology Laboratory
        7.8.1 Bioassay Technology Laboratory Details
        7.8.2 Bioassay Technology Laboratory Major Business
        7.8.3 Bioassay Technology Laboratory Recombinant Hirudin Product and Services
        7.8.4 Bioassay Technology Laboratory Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Bioassay Technology Laboratory Recent Developments/Updates
        7.8.6 Bioassay Technology Laboratory Competitive Strengths & Weaknesses
    7.9 Novus Biologicals
        7.9.1 Novus Biologicals Details
        7.9.2 Novus Biologicals Major Business
        7.9.3 Novus Biologicals Recombinant Hirudin Product and Services
        7.9.4 Novus Biologicals Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Novus Biologicals Recent Developments/Updates
        7.9.6 Novus Biologicals Competitive Strengths & Weaknesses
    7.10 Merck KGaA
        7.10.1 Merck KGaA Details
        7.10.2 Merck KGaA Major Business
        7.10.3 Merck KGaA Recombinant Hirudin Product and Services
        7.10.4 Merck KGaA Recombinant Hirudin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Merck KGaA Recent Developments/Updates
        7.10.6 Merck KGaA Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Recombinant Hirudin Industry Chain
    8.2 Recombinant Hirudin Upstream Analysis
        8.2.1 Recombinant Hirudin Core Raw Materials
        8.2.2 Main Manufacturers of Recombinant Hirudin Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Recombinant Hirudin Production Mode
    8.6 Recombinant Hirudin Procurement Model
    8.7 Recombinant Hirudin Industry Sales Model and Sales Channels
        8.7.1 Recombinant Hirudin Sales Model
        8.7.2 Recombinant Hirudin Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Recombinant Hirudin Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Recombinant Hirudin Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Recombinant Hirudin Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Recombinant Hirudin Production Value Market Share by Region (2018-2023)
    Table 5. World Recombinant Hirudin Production Value Market Share by Region (2024-2029)
    Table 6. World Recombinant Hirudin Production by Region (2018-2023) & (K Units)
    Table 7. World Recombinant Hirudin Production by Region (2024-2029) & (K Units)
    Table 8. World Recombinant Hirudin Production Market Share by Region (2018-2023)
    Table 9. World Recombinant Hirudin Production Market Share by Region (2024-2029)
    Table 10. World Recombinant Hirudin Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Recombinant Hirudin Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Recombinant Hirudin Major Market Trends
    Table 13. World Recombinant Hirudin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Recombinant Hirudin Consumption by Region (2018-2023) & (K Units)
    Table 15. World Recombinant Hirudin Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Recombinant Hirudin Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Recombinant Hirudin Producers in 2022
    Table 18. World Recombinant Hirudin Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Recombinant Hirudin Producers in 2022
    Table 20. World Recombinant Hirudin Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Recombinant Hirudin Company Evaluation Quadrant
    Table 22. World Recombinant Hirudin Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Recombinant Hirudin Production Site of Key Manufacturer
    Table 24. Recombinant Hirudin Market: Company Product Type Footprint
    Table 25. Recombinant Hirudin Market: Company Product Application Footprint
    Table 26. Recombinant Hirudin Competitive Factors
    Table 27. Recombinant Hirudin New Entrant and Capacity Expansion Plans
    Table 28. Recombinant Hirudin Mergers & Acquisitions Activity
    Table 29. United States VS China Recombinant Hirudin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Recombinant Hirudin Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Recombinant Hirudin Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Recombinant Hirudin Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Recombinant Hirudin Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Recombinant Hirudin Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Recombinant Hirudin Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Recombinant Hirudin Production Market Share (2018-2023)
    Table 37. China Based Recombinant Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Recombinant Hirudin Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Recombinant Hirudin Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Recombinant Hirudin Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Recombinant Hirudin Production Market Share (2018-2023)
    Table 42. Rest of World Based Recombinant Hirudin Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Recombinant Hirudin Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Recombinant Hirudin Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Recombinant Hirudin Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Recombinant Hirudin Production Market Share (2018-2023)
    Table 47. World Recombinant Hirudin Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Recombinant Hirudin Production by Type (2018-2023) & (K Units)
    Table 49. World Recombinant Hirudin Production by Type (2024-2029) & (K Units)
    Table 50. World Recombinant Hirudin Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Recombinant Hirudin Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Recombinant Hirudin Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Recombinant Hirudin Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Recombinant Hirudin Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Recombinant Hirudin Production by Application (2018-2023) & (K Units)
    Table 56. World Recombinant Hirudin Production by Application (2024-2029) & (K Units)
    Table 57. World Recombinant Hirudin Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Recombinant Hirudin Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Recombinant Hirudin Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Recombinant Hirudin Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Abbott Basic Information, Manufacturing Base and Competitors
    Table 62. Abbott Major Business
    Table 63. Abbott Recombinant Hirudin Product and Services
    Table 64. Abbott Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Abbott Recent Developments/Updates
    Table 66. Abbott Competitive Strengths & Weaknesses
    Table 67. The Medicines Company Basic Information, Manufacturing Base and Competitors
    Table 68. The Medicines Company Major Business
    Table 69. The Medicines Company Recombinant Hirudin Product and Services
    Table 70. The Medicines Company Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. The Medicines Company Recent Developments/Updates
    Table 72. The Medicines Company Competitive Strengths & Weaknesses
    Table 73. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 74. Teva Pharmaceutical Major Business
    Table 75. Teva Pharmaceutical Recombinant Hirudin Product and Services
    Table 76. Teva Pharmaceutical Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Teva Pharmaceutical Recent Developments/Updates
    Table 78. Teva Pharmaceutical Competitive Strengths & Weaknesses
    Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 80. Pfizer Major Business
    Table 81. Pfizer Recombinant Hirudin Product and Services
    Table 82. Pfizer Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Pfizer Recent Developments/Updates
    Table 84. Pfizer Competitive Strengths & Weaknesses
    Table 85. Pentapharm Basic Information, Manufacturing Base and Competitors
    Table 86. Pentapharm Major Business
    Table 87. Pentapharm Recombinant Hirudin Product and Services
    Table 88. Pentapharm Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Pentapharm Recent Developments/Updates
    Table 90. Pentapharm Competitive Strengths & Weaknesses
    Table 91. PrimeGene Basic Information, Manufacturing Base and Competitors
    Table 92. PrimeGene Major Business
    Table 93. PrimeGene Recombinant Hirudin Product and Services
    Table 94. PrimeGene Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. PrimeGene Recent Developments/Updates
    Table 96. PrimeGene Competitive Strengths & Weaknesses
    Table 97. Aniara Diagnostica Basic Information, Manufacturing Base and Competitors
    Table 98. Aniara Diagnostica Major Business
    Table 99. Aniara Diagnostica Recombinant Hirudin Product and Services
    Table 100. Aniara Diagnostica Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Aniara Diagnostica Recent Developments/Updates
    Table 102. Aniara Diagnostica Competitive Strengths & Weaknesses
    Table 103. Bioassay Technology Laboratory Basic Information, Manufacturing Base and Competitors
    Table 104. Bioassay Technology Laboratory Major Business
    Table 105. Bioassay Technology Laboratory Recombinant Hirudin Product and Services
    Table 106. Bioassay Technology Laboratory Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Bioassay Technology Laboratory Recent Developments/Updates
    Table 108. Bioassay Technology Laboratory Competitive Strengths & Weaknesses
    Table 109. Novus Biologicals Basic Information, Manufacturing Base and Competitors
    Table 110. Novus Biologicals Major Business
    Table 111. Novus Biologicals Recombinant Hirudin Product and Services
    Table 112. Novus Biologicals Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Novus Biologicals Recent Developments/Updates
    Table 114. Merck KGaA Basic Information, Manufacturing Base and Competitors
    Table 115. Merck KGaA Major Business
    Table 116. Merck KGaA Recombinant Hirudin Product and Services
    Table 117. Merck KGaA Recombinant Hirudin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 118. Global Key Players of Recombinant Hirudin Upstream (Raw Materials)
    Table 119. Recombinant Hirudin Typical Customers
    Table 120. Recombinant Hirudin Typical Distributors
List of Figure
    Figure 1. Recombinant Hirudin Picture
    Figure 2. World Recombinant Hirudin Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Recombinant Hirudin Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Recombinant Hirudin Production (2018-2029) & (K Units)
    Figure 5. World Recombinant Hirudin Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Recombinant Hirudin Production Value Market Share by Region (2018-2029)
    Figure 7. World Recombinant Hirudin Production Market Share by Region (2018-2029)
    Figure 8. North America Recombinant Hirudin Production (2018-2029) & (K Units)
    Figure 9. Europe Recombinant Hirudin Production (2018-2029) & (K Units)
    Figure 10. China Recombinant Hirudin Production (2018-2029) & (K Units)
    Figure 11. Japan Recombinant Hirudin Production (2018-2029) & (K Units)
    Figure 12. Recombinant Hirudin Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Recombinant Hirudin Consumption (2018-2029) & (K Units)
    Figure 15. World Recombinant Hirudin Consumption Market Share by Region (2018-2029)
    Figure 16. United States Recombinant Hirudin Consumption (2018-2029) & (K Units)
    Figure 17. China Recombinant Hirudin Consumption (2018-2029) & (K Units)
    Figure 18. Europe Recombinant Hirudin Consumption (2018-2029) & (K Units)
    Figure 19. Japan Recombinant Hirudin Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Recombinant Hirudin Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Recombinant Hirudin Consumption (2018-2029) & (K Units)
    Figure 22. India Recombinant Hirudin Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Recombinant Hirudin by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Hirudin Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Hirudin Markets in 2022
    Figure 26. United States VS China: Recombinant Hirudin Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Recombinant Hirudin Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Recombinant Hirudin Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Recombinant Hirudin Production Market Share 2022
    Figure 30. China Based Manufacturers Recombinant Hirudin Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Recombinant Hirudin Production Market Share 2022
    Figure 32. World Recombinant Hirudin Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Recombinant Hirudin Production Value Market Share by Type in 2022
    Figure 34. 12000ATU/mg
    Figure 35. 16000ATU/mg
    Figure 36. World Recombinant Hirudin Production Market Share by Type (2018-2029)
    Figure 37. World Recombinant Hirudin Production Value Market Share by Type (2018-2029)
    Figure 38. World Recombinant Hirudin Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Recombinant Hirudin Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Recombinant Hirudin Production Value Market Share by Application in 2022
    Figure 41. Thrombosis Disease
    Figure 42. Tumor Disease
    Figure 43. World Recombinant Hirudin Production Market Share by Application (2018-2029)
    Figure 44. World Recombinant Hirudin Production Value Market Share by Application (2018-2029)
    Figure 45. World Recombinant Hirudin Average Price by Application (2018-2029) & (US$/Unit)
    Figure 46. Recombinant Hirudin Industry Chain
    Figure 47. Recombinant Hirudin Procurement Model
    Figure 48. Recombinant Hirudin Sales Model
    Figure 49. Recombinant Hirudin Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source